Non-invasive Prenatal Testing Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Non-invasive Prenatal Testing Market to 2027 - Global Analysis and Forecasts By Product (Assay Kits and Reagents, Consumables, Disposables, Next-Generation Sequencing System, Instruments, PCR instruments, Ultrasound Devices, Microarrays, others); Method (Ultrasound Detection, Cell-Free DNA in Maternal Plasma Tests, Biochemical Screening Tests, Fetal Cells in Maternal Plasma Tests); Application (Trisomy, Micro Deletion Syndrome, Others); End User (Diagnostic Laboratories, Hospitals)

Report Code: TIPRE00005191 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Non-invasive Prenatal Testing is a new genetic process that examines the fetal cell-free DNA present in the mother's blood serum for the detection of common fetal aneuploidies.

MARKET DYNAMICS
The Non-invasive Prenatal Testing market is anticipated to grow in the forecast, owing to the factors such as growing reimbursements for the NIPT sector, increasing shift from invasive methods to noninvasive methods, growth in the risk of chromosomal abnormalities in babies, launch and development of advanced and novel technologies and growing maternal age. Nevertheless, lack of skilled professionals and stringent regulatory guidelines is expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Non-invasive Prenatal Testing Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Non-invasive Prenatal Testing market with detailed market segmentation by Product, Method, Application, End User and geography. The global Non-invasive Prenatal Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-invasive Prenatal Testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Non-invasive Prenatal Testing market is segmented on the basis of Product, Method, Application and End User. Based on Product the market is segmented into Assay Kits and Reagents, Consumables, Disposables, Next-Generation Sequencing System, Instruments, PCR instruments, Ultrasound Devices, Microarrays, others. Based on Method the market is segmented into Ultrasound Detection, Cell-Free DNA in Maternal Plasma Tests, Biochemical Screening Tests, Fetal Cells in Maternal Plasma Tests. Based on Application the market is segmented into Trisomy, Micro Deletion Syndrome, Others. Based on End User the market is segmented into Diagnostic Laboratories, Hospitals.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Non-invasive Prenatal Testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Non-invasive Prenatal Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Non-invasive Prenatal Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Non-invasive Prenatal Testing market in these regions.

MARKET PLAYERS
The reports cover key developments in the Non-invasive Prenatal Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Non-invasive Prenatal Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Non-invasive Prenatal Testing market in the global market. Below mentioned is the list of few companies engaged in the Non-invasive Prenatal Testing market.

The report also includes the profiles of Non-invasive Prenatal Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Ge Healthcare
  • Koninklijke Philips N.V
  • Illumina, Inc
  • Thermo Fisher Scientific, Inc
  • F. Hoffman-La Roche Ltd
  • Pacific Biosciences of California, Inc
  • Perkinelmer, Inc
  • Qiagen N.V
  • Agilent Technologies, Inc
  • BGI
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non-invasive Prenatal Testing Market - By Product
1.3.2 Non-invasive Prenatal Testing Market - By Method
1.3.3 Non-invasive Prenatal Testing Market - By Application
1.3.4 Non-invasive Prenatal Testing Market - By End User
1.3.5 Non-invasive Prenatal Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON-INVASIVE PRENATAL TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON-INVASIVE PRENATAL TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON-INVASIVE PRENATAL TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. NON-INVASIVE PRENATAL TESTING - GLOBAL MARKET OVERVIEW
6.2. NON-INVASIVE PRENATAL TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON-INVASIVE PRENATAL TESTING MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ASSAY KITS AND REAGENTS
7.3.1. Overview
7.3.2. Assay Kits and Reagents Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.5. DISPOSABLES
7.5.1. Overview
7.5.2. Disposables Market Forecast and Analysis
7.6. NEXT-GENERATION SEQUENCING SYSTEM
7.6.1. Overview
7.6.2. Next-Generation Sequencing System Market Forecast and Analysis
7.7. INSTRUMENTS
7.7.1. Overview
7.7.2. Instruments Market Forecast and Analysis
7.8. PCR INSTRUMENTS
7.8.1. Overview
7.8.2. PCR instruments Market Forecast and Analysis
7.9. ULTRASOUND DEVICES
7.9.1. Overview
7.9.2. Ultrasound Devices Market Forecast and Analysis
7.10. MICROARRAYS
7.10.1. Overview
7.10.2. Microarrays Market Forecast and Analysis
7.11. OTHERS
7.11.1. Overview
7.11.2. others Market Forecast and Analysis
8. NON-INVASIVE PRENATAL TESTING MARKET - REVENUE AND FORECASTS TO 2027 - METHOD
8.1. OVERVIEW
8.2. METHOD MARKET FORECASTS AND ANALYSIS
8.3. ULTRASOUND DETECTION
8.3.1. Overview
8.3.2. Ultrasound Detection Market Forecast and Analysis
8.4. CELL-FREE DNA IN MATERNAL PLASMA TESTS
8.4.1. Overview
8.4.2. Cell-Free DNA in Maternal Plasma Tests Market Forecast and Analysis
8.5. BIOCHEMICAL SCREENING TESTS
8.5.1. Overview
8.5.2. Biochemical Screening Tests Market Forecast and Analysis
8.6. FETAL CELLS IN MATERNAL PLASMA TESTS
8.6.1. Overview
8.6.2. Fetal Cells in Maternal Plasma Tests Market Forecast and Analysis
9. NON-INVASIVE PRENATAL TESTING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. TRISOMY
9.3.1. Overview
9.3.2. Trisomy Market Forecast and Analysis
9.4. MICRO DELETION SYNDROME
9.4.1. Overview
9.4.2. Micro Deletion Syndrome Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. NON-INVASIVE PRENATAL TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. DIAGNOSTIC LABORATORIES
10.3.1. Overview
10.3.2. Diagnostic Laboratories Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
11. NON-INVASIVE PRENATAL TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Non-invasive Prenatal Testing Market Overview
11.1.2 North America Non-invasive Prenatal Testing Market Forecasts and Analysis
11.1.3 North America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Product
11.1.4 North America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Method
11.1.5 North America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Application
11.1.6 North America Non-invasive Prenatal Testing Market Forecasts and Analysis - By End User
11.1.7 North America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Non-invasive Prenatal Testing Market
11.1.7.1.1 United States Non-invasive Prenatal Testing Market by Product
11.1.7.1.2 United States Non-invasive Prenatal Testing Market by Method
11.1.7.1.3 United States Non-invasive Prenatal Testing Market by Application
11.1.7.1.4 United States Non-invasive Prenatal Testing Market by End User
11.1.7.2 Canada Non-invasive Prenatal Testing Market
11.1.7.2.1 Canada Non-invasive Prenatal Testing Market by Product
11.1.7.2.2 Canada Non-invasive Prenatal Testing Market by Method
11.1.7.2.3 Canada Non-invasive Prenatal Testing Market by Application
11.1.7.2.4 Canada Non-invasive Prenatal Testing Market by End User
11.1.7.3 Mexico Non-invasive Prenatal Testing Market
11.1.7.3.1 Mexico Non-invasive Prenatal Testing Market by Product
11.1.7.3.2 Mexico Non-invasive Prenatal Testing Market by Method
11.1.7.3.3 Mexico Non-invasive Prenatal Testing Market by Application
11.1.7.3.4 Mexico Non-invasive Prenatal Testing Market by End User
11.2. EUROPE
11.2.1 Europe Non-invasive Prenatal Testing Market Overview
11.2.2 Europe Non-invasive Prenatal Testing Market Forecasts and Analysis
11.2.3 Europe Non-invasive Prenatal Testing Market Forecasts and Analysis - By Product
11.2.4 Europe Non-invasive Prenatal Testing Market Forecasts and Analysis - By Method
11.2.5 Europe Non-invasive Prenatal Testing Market Forecasts and Analysis - By Application
11.2.6 Europe Non-invasive Prenatal Testing Market Forecasts and Analysis - By End User
11.2.7 Europe Non-invasive Prenatal Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Non-invasive Prenatal Testing Market
11.2.7.1.1 Germany Non-invasive Prenatal Testing Market by Product
11.2.7.1.2 Germany Non-invasive Prenatal Testing Market by Method
11.2.7.1.3 Germany Non-invasive Prenatal Testing Market by Application
11.2.7.1.4 Germany Non-invasive Prenatal Testing Market by End User
11.2.7.2 France Non-invasive Prenatal Testing Market
11.2.7.2.1 France Non-invasive Prenatal Testing Market by Product
11.2.7.2.2 France Non-invasive Prenatal Testing Market by Method
11.2.7.2.3 France Non-invasive Prenatal Testing Market by Application
11.2.7.2.4 France Non-invasive Prenatal Testing Market by End User
11.2.7.3 Italy Non-invasive Prenatal Testing Market
11.2.7.3.1 Italy Non-invasive Prenatal Testing Market by Product
11.2.7.3.2 Italy Non-invasive Prenatal Testing Market by Method
11.2.7.3.3 Italy Non-invasive Prenatal Testing Market by Application
11.2.7.3.4 Italy Non-invasive Prenatal Testing Market by End User
11.2.7.4 Spain Non-invasive Prenatal Testing Market
11.2.7.4.1 Spain Non-invasive Prenatal Testing Market by Product
11.2.7.4.2 Spain Non-invasive Prenatal Testing Market by Method
11.2.7.4.3 Spain Non-invasive Prenatal Testing Market by Application
11.2.7.4.4 Spain Non-invasive Prenatal Testing Market by End User
11.2.7.5 United Kingdom Non-invasive Prenatal Testing Market
11.2.7.5.1 United Kingdom Non-invasive Prenatal Testing Market by Product
11.2.7.5.2 United Kingdom Non-invasive Prenatal Testing Market by Method
11.2.7.5.3 United Kingdom Non-invasive Prenatal Testing Market by Application
11.2.7.5.4 United Kingdom Non-invasive Prenatal Testing Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Non-invasive Prenatal Testing Market Overview
11.3.2 Asia-Pacific Non-invasive Prenatal Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Non-invasive Prenatal Testing Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Non-invasive Prenatal Testing Market Forecasts and Analysis - By Method
11.3.5 Asia-Pacific Non-invasive Prenatal Testing Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Non-invasive Prenatal Testing Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Non-invasive Prenatal Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Non-invasive Prenatal Testing Market
11.3.7.1.1 Australia Non-invasive Prenatal Testing Market by Product
11.3.7.1.2 Australia Non-invasive Prenatal Testing Market by Method
11.3.7.1.3 Australia Non-invasive Prenatal Testing Market by Application
11.3.7.1.4 Australia Non-invasive Prenatal Testing Market by End User
11.3.7.2 China Non-invasive Prenatal Testing Market
11.3.7.2.1 China Non-invasive Prenatal Testing Market by Product
11.3.7.2.2 China Non-invasive Prenatal Testing Market by Method
11.3.7.2.3 China Non-invasive Prenatal Testing Market by Application
11.3.7.2.4 China Non-invasive Prenatal Testing Market by End User
11.3.7.3 India Non-invasive Prenatal Testing Market
11.3.7.3.1 India Non-invasive Prenatal Testing Market by Product
11.3.7.3.2 India Non-invasive Prenatal Testing Market by Method
11.3.7.3.3 India Non-invasive Prenatal Testing Market by Application
11.3.7.3.4 India Non-invasive Prenatal Testing Market by End User
11.3.7.4 Japan Non-invasive Prenatal Testing Market
11.3.7.4.1 Japan Non-invasive Prenatal Testing Market by Product
11.3.7.4.2 Japan Non-invasive Prenatal Testing Market by Method
11.3.7.4.3 Japan Non-invasive Prenatal Testing Market by Application
11.3.7.4.4 Japan Non-invasive Prenatal Testing Market by End User
11.3.7.5 South Korea Non-invasive Prenatal Testing Market
11.3.7.5.1 South Korea Non-invasive Prenatal Testing Market by Product
11.3.7.5.2 South Korea Non-invasive Prenatal Testing Market by Method
11.3.7.5.3 South Korea Non-invasive Prenatal Testing Market by Application
11.3.7.5.4 South Korea Non-invasive Prenatal Testing Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Non-invasive Prenatal Testing Market Overview
11.4.2 Middle East and Africa Non-invasive Prenatal Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Non-invasive Prenatal Testing Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Non-invasive Prenatal Testing Market Forecasts and Analysis - By Method
11.4.5 Middle East and Africa Non-invasive Prenatal Testing Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Non-invasive Prenatal Testing Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Non-invasive Prenatal Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Non-invasive Prenatal Testing Market
11.4.7.1.1 South Africa Non-invasive Prenatal Testing Market by Product
11.4.7.1.2 South Africa Non-invasive Prenatal Testing Market by Method
11.4.7.1.3 South Africa Non-invasive Prenatal Testing Market by Application
11.4.7.1.4 South Africa Non-invasive Prenatal Testing Market by End User
11.4.7.2 Saudi Arabia Non-invasive Prenatal Testing Market
11.4.7.2.1 Saudi Arabia Non-invasive Prenatal Testing Market by Product
11.4.7.2.2 Saudi Arabia Non-invasive Prenatal Testing Market by Method
11.4.7.2.3 Saudi Arabia Non-invasive Prenatal Testing Market by Application
11.4.7.2.4 Saudi Arabia Non-invasive Prenatal Testing Market by End User
11.4.7.3 U.A.E Non-invasive Prenatal Testing Market
11.4.7.3.1 U.A.E Non-invasive Prenatal Testing Market by Product
11.4.7.3.2 U.A.E Non-invasive Prenatal Testing Market by Method
11.4.7.3.3 U.A.E Non-invasive Prenatal Testing Market by Application
11.4.7.3.4 U.A.E Non-invasive Prenatal Testing Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Non-invasive Prenatal Testing Market Overview
11.5.2 South and Central America Non-invasive Prenatal Testing Market Forecasts and Analysis
11.5.3 South and Central America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Product
11.5.4 South and Central America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Method
11.5.5 South and Central America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Application
11.5.6 South and Central America Non-invasive Prenatal Testing Market Forecasts and Analysis - By End User
11.5.7 South and Central America Non-invasive Prenatal Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Non-invasive Prenatal Testing Market
11.5.7.1.1 Brazil Non-invasive Prenatal Testing Market by Product
11.5.7.1.2 Brazil Non-invasive Prenatal Testing Market by Method
11.5.7.1.3 Brazil Non-invasive Prenatal Testing Market by Application
11.5.7.1.4 Brazil Non-invasive Prenatal Testing Market by End User
11.5.7.2 Argentina Non-invasive Prenatal Testing Market
11.5.7.2.1 Argentina Non-invasive Prenatal Testing Market by Product
11.5.7.2.2 Argentina Non-invasive Prenatal Testing Market by Method
11.5.7.2.3 Argentina Non-invasive Prenatal Testing Market by Application
11.5.7.2.4 Argentina Non-invasive Prenatal Testing Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NON-INVASIVE PRENATAL TESTING MARKET, KEY COMPANY PROFILES
13.1. GE HEALTHCARE
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. KONINKLIJKE PHILIPS N.V
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ILLUMINA, INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. THERMO FISHER SCIENTIFIC, INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. F. HOFFMAN-LA ROCHE LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PACIFIC BIOSCIENCES OF CALIFORNIA, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PERKINELMER, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. QIAGEN N.V
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. AGILENT TECHNOLOGIES, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BEIJING GENOMICS INSTITUTE.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Ge Healthcare
- Koninklijke Philips N.V
- Illumina, Inc
- Thermo Fisher Scientific, Inc
- F. Hoffman-La Roche Ltd
- Pacific Biosciences of California, Inc
- Perkinelmer, Inc
- Qiagen N.V
- Agilent Technologies, Inc
- BGI